In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival.

MLA

Said, Ibrahim, et al. “In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging Is Not a Prognostic Marker for Survival.” Annals of Surgical Oncology, vol. 29, no. 8, Aug. 2022, pp. 5256–62. EBSCOhost, https://doi.org/10.1245/s10434-022-11718-7.

APA

Said, I., Ubink, I., Ewalds, R. S. G., Arkesteijn, J. G. T., Verheul, H. M. W., de Wilt, J. H. W., Dekker, H. M., Bremers, A. J. A., & de Reuver, P. R. (2022). In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival. Annals of Surgical Oncology, 29(8), 5256–5262. https://doi.org/10.1245/s10434-022-11718-7

Chicago

Said, Ibrahim, Inge Ubink, Roos S G Ewalds, Johanna G T Arkesteijn, Henk M W Verheul, Johannes H W de Wilt, Helena M Dekker, Andreas J A Bremers, and Philip R de Reuver. 2022. “In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging Is Not a Prognostic Marker for Survival.” Annals of Surgical Oncology 29 (8): 5256–62. doi:10.1245/s10434-022-11718-7.